Cite
HARVARD Citation
Kertes, J. et al. (2023). Association Between AZD7442 (Tixagevimab-Cilgavimab) Administration and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection, Hospitalization, and Mortality. Clinical infectious diseases. pp. e126-e132. [Online].